Pradeep Nagisetty, Regional Sales Manager India & Sub Continent, Abbott Informatics STARLIMS, Hyderabad
Can you tell us about the major product releases of STARLIMS since 2020?
It’s the result of regular collaborations with our fantastic customer base, allowing us to hear from those that will benefit the most from this. We then take into consideration the overall market trends to enable our R&D and product teams to incorporated this feedback into new product releases, technology upgrades, critical bug fixes, data integrity improvement, performance improvements and cyber security enhancements. Our commitment to continual releases and improvements provides our customers with a LIMS solution that will remain relevant.
Since 2020, we have already released two minor versions of STARLIMS QM solution for the pharmaceutical and other manufacturing industries. We offer an Automated Validation Framework and Testing Kit that reduce the time, cost, resources and complexity over the manual testing methods. With STARLIMS QM V12.2 released in April 2021, we have brought new integration capabilities – SAP4/HANA Integration, interface with Biovia Draw and Biovia Direct for chemical structures, Thermo Chromeleon 7.3 CDS interface upgrade, Waters Empower 3 FR5 CDS interface upgrade.
This year we have the new SDMS product – Scientific Data Management System. A standalone SDMS software that helps with automatic lab equipment integration, raw data and process data capturing, data storage in folders, search and reporting, long term data storage and archival, assuring highest data integrity in the regulatory labs.
For the first time, we launched LES – Lab Execution System product. With our LES, our customers can ensure Standard Operating Procedures (SOPs) are being followed and tasks are being developed in a compliant and controlled manner for regulated labs. This is a fully touch enabled interface system that works seamlessly on smart devices and is fully mobile enabled in the labs.
We have a very strong roadmap in place and will bring more advanced products and tools to the market continually.
What are the major challenges for companies in life science sector in India?
Continue reading your story on the app
Continue reading your story in the magazine
“R&D outsourcing has become a ‘must have' than ‘good-to have' strategy”
Aragen Life Sciences (formerly GVK BIO), a leading contract research and development organisation headquartered in Hyderabad, is marking its transition to a new brand identity in its 20th year. Established in 2001, the company is poised for growth in the outsourced discovery, development, and manufacturing services sector across both large and small molecule platforms with new investments and collaborations. In conversation with BioSpectrum, Manni Kantipudi, Chief Executive Officer, Aragen Life Sciences, Hyderabad reveals more about the company’s recent rebranding and growth plans. Edited excerpts;
Premas Biotech to commercialise VLP vaccine tech against Delta variant
Gurugram-based Premas Biotech has signed a licensing deal with Oravax Medical for the development and commercialisation of its virus-like-particle COVID-19 vaccine technology.
SARS-CoV-2: A Biochemical Treatise on its Past, Present & Future
The SARS-CoV-2 pandemic is unprecedented but equally unprecedented is the contribution of scientists who have helped us in understanding the mechanisms by which it infects human beings and also, developing a variety of vaccines to protect the masses, in a year’s time, which can be called truly groundbreaking. This article gives an overview of the progress made by scientists around the world working round the clock in developing an understanding of the SARS-CoV-2 evolution and COVID-19 disease pathogenesis, and also makes an attempt to suggest the possible ways of coping with this pandemic if we have to co-exist with it forever!
Merck launches Pergoveris Pen for fertility treatment in India
Merck Specialties, the healthcare business of Merck in India, has launched Pergoveris Pen for advanced infertility treatment in India.
How tech innovations impact cardiac care
Cardiac care has seen a transformation over the years with technology playing an important role. Armed with Artificial intelligence (AI) and machine learning (ML), cardiac care providers, with the right technology, have received the right impetus to revolutionise treatment mechanisms. Let us delve into the new technologies which the industry is offering to mankind and decipher the way forward.
GUNG-HO PHARMA R&D INVESTMENTS SURPASS $3B
While the pharmaceutical industry helped combat COVID-19, from R&D actions on potential treatment strategies to balancing the medicines supply chain in the time of crisis, it struggled to maintain the natural market flow. As a result, many pharma companies had to abort some of their ongoing R&D investment plans. However for FY20-21, the average R&D expenses constituted 7.2 per cent of the total revenues of the pharma companies, with Lupin, Alembic Pharma and Dr. Reddy’s spending more than others. The cumulative R&D expenditure of the leading 10 pharma companies has been around Rs 10,627 crore ($1.43 billion) in the previous fiscal. This figure eventually reaches an approximate amount of Rs 22,500 crore ($3.03 billion) after considering the cumulative expenditure by other small and medium players of the India pharma industry.
Glenmark ties up with SaNOtize to commercialise COVID-19 nasal spray
Mumbai-based Glenmark Pharmaceuticals and Canadian biotech firm SaNOtize Research & Development Corporation
CEPI prioritises Rift Valley fever vax
Sep 01, Norway-based Coalition for Epidemic Preparedness Innovations (CEPI) has signed an implementing partner agreement with Integrum Scientific (US) as part of its ongoing efforts to combat Rift Valley fever (RVF)—one of its priority diseases with epidemic potential.
3D printing moulds healthcare innovations
Pharmaceuticals, bio-medicine, aviation, and automobiles industries have rapidly adopted 3D printing over the years, worldwide, to develop new solutions and prototypes. It is also helping many industries, healthcare, in particular, increase productivity. Despite all its advantages, 3D printing technology is currently posing a number of challenges in the market such as initial costs, limitation to the metals and plastics used for 3D printing, lack of policy standardisation, etc.
Mynvax Offers ‘Warm Vaccine' For COVID-19
Biotech startup Mynvax, incubated at the Indian Institute of Science (IISc) in Bengaluru, has developed heat-tolerant COVID-19 vaccine formulations.
Simple STEP STOOL
A fresh approach to a Shaker tradition
As tough as they come
Create a convertible bedroom with cool cabinetry, the right hardware kit, and clear instructions.
FUN with FRIDGE MAGNETS
Have a micro-blast turning precious scrap into useful hangers-on
Dramatic curves from your table saw
Arts & Crafts WALL CLOCK
My mission to create a Craftsman clock on the table saw
IRELAND INVESTIGATES TIKTOK OVER CHILD, CHINA DATA CONCERNS
TikTok is facing two EU data privacy investigations, one into its handling of children’s personal data and another over its data transfers to China.
TESLA BUILDS 1ST STORE ON TRIBAL LAND, DODGES STATE CAR LAWS
Carmaker Tesla has opened a store and repair shop on Native American land for the first time, marking a new approach to its years-long fight to sell cars directly to consumers and cut car dealerships out of the process.
NUCLEAR SUBMARINE DEAL WILL RESHAPE INDO-PACIFIC RELATIONS
The U.S., Britain and Australia have announced they’re forming a new security alliance that will help equip Australia with nuclear-powered submarines. The alliance will see a reshaping of relations in the Indo-Pacific region and beyond. Here’s what it might mean for various players:
INTERNET FUNDING RULE COULD FAVOR RURAL AREAS OVER CITIES
Cities and urban counties across the U.S. are raising concerns that a recent rule from President Joe Biden’s administration could preclude them from tapping into $350 billion of coronavirus relief aid to expand high-speed internet connections.